OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	123
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	90
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	80
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	75
A case of rare metachronous four primary carcinoma	70
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	68
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	67
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	66
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	61
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	61
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence	61
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	59
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	59
Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo	50
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	49
Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma	49
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	49
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	45
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	44
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	42
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	42
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	42
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	42
Expression and clinical prognostic value of CYB561 in breast cancer	41
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study	41

Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	40
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	40
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	38
Breast cancer prediction using different machine learning methods applying multi factors	37
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	35
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	34
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	34
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study	34
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	34